132 related articles for article (PubMed ID: 9124866)
1. Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.
Balcabao IP; Aguilar L; Martín M; García Y; Dal-Ré R; Prieto J
Antimicrob Agents Chemother; 1996 Dec; 40(12):2904-6. PubMed ID: 9124866
[TBL] [Abstract][Full Text] [Related]
2. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L
J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
Aguilar L; Rosendo J; Balcabao IP; Martín M; Giménez MJ; Frías J; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1389-91. PubMed ID: 9174206
[TBL] [Abstract][Full Text] [Related]
4. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
[No Abstract] [Full Text] [Related]
7. Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
Jones RN; Johnson DM
Diagn Microbiol Infect Dis; 1998 Jun; 31(2):373-6. PubMed ID: 9635912
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model.
Gustafsson I; Löwdin E; Odenholt I; Cars O
Antimicrob Agents Chemother; 2001 Sep; 45(9):2436-40. PubMed ID: 11502511
[TBL] [Abstract][Full Text] [Related]
9. Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
Vergnaud M; Prévost JN; Malbruny B; Brun J; Leclercq R
Clin Microbiol Infect; 2000 May; 6(5):283-4. PubMed ID: 11168130
[No Abstract] [Full Text] [Related]
10. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Murphy ME; Powell E; Courter J; Mortensen JE
BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
12. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Goldstein FW
Scand J Infect Dis; 1997; 29(3):255-7. PubMed ID: 9255885
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
[TBL] [Abstract][Full Text] [Related]
14. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation.
Prieto J; Giménez MJ; Balcabao IP; Gómez-Lus ML; Aguilar L
J Chemother; 1999 Oct; 11(5):345-8. PubMed ID: 10632379
[TBL] [Abstract][Full Text] [Related]
15. Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Cappelletty DM; Rybak MJ
Antimicrob Agents Chemother; 1996 May; 40(5):1148-52. PubMed ID: 8723456
[TBL] [Abstract][Full Text] [Related]
16. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Matsumoto Y
Chemotherapy; 1998 Sep; 44 Suppl 1():6-9. PubMed ID: 9797416
[TBL] [Abstract][Full Text] [Related]
17. Penicillin-resistant Streptococcus pneumoniae.
Hedge DD
S D J Med; 1996 Nov; 49(11):423-4. PubMed ID: 8973136
[No Abstract] [Full Text] [Related]
18. Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
Thornsberry C; Burton PH; Vanderhoof BH
Diagn Microbiol Infect Dis; 1996 Jun; 25(2):89-95. PubMed ID: 8882895
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
Bell SM; Gatus BJ; Pham JN
Med J Aust; 1996 Feb; 164(3):188. PubMed ID: 8628145
[No Abstract] [Full Text] [Related]
20. In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Verhaegen J; Verbist L
J Antimicrob Chemother; 1998 Mar; 41(3):381-5. PubMed ID: 9578165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
